Actually, the altered platelet sensitivity to NO/cGMP/PKG and PGI2/cAMP/PKA pathways in obesity is restored by weight reduction of at least 10% of the initial body weight and this phenomenon is also accompanied by an improvement of insulin resistance and a decrease of markers of inflammation [61] and synthesis of isoprostanes [126]. This evidence concerns the gene INS and obesity disorder.